Corrigendum to "safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1362 patients" (Int. J. Cardiol. (2015) 203 (906-908))

Garg, J., Chaudhary, R., Krishnamoorthy, P., Shah, N., Natale, A., & Bozorgnia, B. (2016, April 15). Corrigendum to “safety and efficacy of uninterrupted periprocedural rivaroxaban in patients undergoing atrial fibrillation catheter ablation: A metaanalysis of 1362 patients” (Int. J. Cardiol. (2015) 203 (906-908)). International Journal of Cardiology. Elsevier Ireland Ltd. https://doi.org/10.1016/j.ijcard.2016.02.019